Doxorubicin hydrochloride

Blue Faery: The Adrienne Wilson Liver Cancer Association



Doxorubicin hydrochloride

Print Friendly, PDF & Email

An intravenous cytotoxic anthracycline antibiotic drug, doxorubicin hydrochloride has a toxic effect on malignant cells. Chemically, it is 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy] -7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, hydrochloride (8S-cis)-. Of the cancers commonly listed to respond well to doxorubicin, liver cancer is not found although it is commonly part of liver cancer treatment. Possible side effects include: nausea, hair loss, ulcers, mouth sores, difficulty swallowing, anemia, discolored (usually red) urine, sensitivity to the sun, and diarrhea.

Scroll Up